SILVACO GROUP, INC. (SVCO) SEC News April 27, 2026, 21:02 UTC 1 1 comments Lee Hau L. 🟢 acquired 2.7K shares of Silvaco Group, Inc. (SVCO) Transaction Date: Apr 22, 2026 | Filing ID: 027606 Comment Full text
PRINCETON BANCORP, INC. (BPRN) SEC News April 27, 2026, 21:02 UTC 0 1 comments (99% Neutral) PRINCETON BANCORP, INC. (BPRN) Announces Regulatory Update Comment Full text
IQVIA HOLDINGS INC. (IQV) SEC News April 27, 2026, 21:01 UTC 0 1 comments Director Fasano Jim 🟢 acquired 1.6K shares (1 derivative) of IQVIA HOLDINGS INC. (IQV) Transaction Date: Apr 23, 2026 | Filing ID: 027605 Comment Full text
CLEARSIGN TECHNOLOGIES CORP (CLIR) SEC News April 27, 2026, 21:01 UTC 0 0 comments New Form 4/A - ClearSign Technologies Corp <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0001104659-26-049608 <b>Size:</b> 7 KB Comment Full text
WEREWOLF THERAPEUTICS, INC. (HOWL) SEC News April 27, 2026, 21:01 UTC 0 1 comments 📋 MPM Asset Management LLC (Shareholder) plans to sell 21K shares of Werewolf Therapeutics, Inc. (at $0.81 each, total $17K) Filed: Apr 27, 2026 | ID: 027603 Comment Full text
WEREWOLF THERAPEUTICS, INC. (HOWL) SEC News April 27, 2026, 21:01 UTC 0 1 comments 📋 MPM Asset Management Investors BV2014 LLC (Shareholder) plans to sell 4K shares of Werewolf Therapeutics, Inc. (at $0.81 each, total $4K) Filed: Apr 27, 2026 | ID: 027601 Comment Full text
SILVACO GROUP, INC. (SVCO) SEC News April 27, 2026, 21:00 UTC 0 1 comments Molloie William H. Jr. 🟢 acquired 2.0K shares of Silvaco Group, Inc. (SVCO) Transaction Date: Apr 22, 2026 | Filing ID: 027599 Comment Full text
WEREWOLF THERAPEUTICS, INC. (HOWL) SEC News April 27, 2026, 21:00 UTC 0 1 comments 📋 MPM BioVentures 2014 (B), L.P. (Shareholder) plans to sell 9K shares of Werewolf Therapeutics, Inc. (at $0.81 each, total $7K) Filed: Apr 27, 2026 | ID: 027598 Comment Full text
LIGHTBRIDGE CORP (LTBR) SEC News April 27, 2026, 21:00 UTC 0 1 comments (10% Negative) LIGHTBRIDGE CORP (LTBR) Reports Q2 2026 Financial Results Comment Full text
WEREWOLF THERAPEUTICS, INC. (HOWL) SEC News April 27, 2026, 21:00 UTC 0 1 comments 📋 UBS Oncology Impact Fund, L.P. (Shareholder) plans to sell 108K shares of Werewolf Therapeutics, Inc. (at $0.81 each, total $88K) Filed: Apr 27, 2026 | ID: 027597 Comment Full text